Therapy in Patients with Hematologic Malignancies, Seroconversion Rates, and SARS-CoV-2 Vaccination. | Oncologist;27(11): e916, 2022 Nov 03. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

WHO COVID-19 Research Database

News/Update/Help

Advanced Search

The WHO Covid-19 Research Database is a resource created in response to the Public Health Emergency of International Concern (PHEIC). Its content remains searchable and spans the time period March 2020 to June 2023. Since June 2023, manual updates to the database have been discontinued.

Therapy in Patients with Hematologic Malignancies, Seroconversion Rates, and SARS-CoV-2 Vaccination.

Sriwijitalai, Won; Wiwanitkit, Viroj.

Sriwijitalai W; Private Academic Consultant, Dimapur, India.
Wiwanitkit V; Honorary Professor, Dr DY Patil University, Pune, India.

Oncologist ; 27(11): e916, 2022 Nov 03.

Article in English | MEDLINE | ID: covidwho-2018047

Subject(s)

COVID-19; Hematologic Neoplasms; Humans; Seroconversion; COVID-19 Vaccines/therapeutic use; SARS-CoV-2; COVID-19/prevention & control; Vaccination; Hematologic Neoplasms/therapy

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Hematologic Neoplasms / COVID-19 Topics: Vaccines Limits: Humans Language: English Journal: Oncologist Journal subject: Neoplasms Year: 2022 Document Type: Article Affiliation country: Oncolo

Similar

MEDLINE

LILACS

LIS

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Hematologic Neoplasms / COVID-19 Topics: Vaccines Limits: Humans Language: English Journal: Oncologist Journal subject: Neoplasms Year: 2022 Document Type: Article Affiliation country: Oncolo